Kunststoff Inds. (523594)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹30.13 |
| Market Cap | ₹20.76 Cr |
| P/E Ratio | 16.46 |
| ROCE | 17.04% |
| ROE | 8.8% |
| Dividend Yield | 0% |
| Profit Growth | 23.33% |
| Debt/Equity | — |
| Sales Growth | 2.13% |
| 52-Week Range | ₹18.15 — ₹32.5 |
| Sector | Industrial Products |
| Book Value | ₹18.14 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹30.13, Kunststoff Inds. is a microcap with a market cap of just ₹21 Cr. Benjamin Graham would remind me that small size brings risk, but also the possibility of mispricing. However, I must deal with what I know. The latest quarter shows sales of ₹3 Cr and net profit of ₹0 Cr – that rounds to nothing. Over a year, profit growth of 23.33% looks attractive, but this is against a very low base, and sales growth is only 2.13%. A business that cannot grow its top line at a decent rate will struggle to compound value. Return on equity is 8.80%, below the 15% I prefer. Yet ROCE is 17.04%, which suggests the operating side is more efficient than the equity return implies. Debt-to-equity is not available, so I cannot confirm the balance sheet strength. The Piotroski F-Score of 7 out of 9 is solid, indicating good financial health. But with a P/E of 16.46 and price-to-book of 1.66, I am not being offered a bargain. Book value is ₹18.14, so I'm paying a 66% premium for a slow-growing plastics business. The dividend yield is zero, so all my return depends on earnings growth or multiple expansion. In the Graham style, I require a margin of safety. Here, I see a decent ROCE and a reasonable Piotroski score, but negligible topline growth and a quarterly profit that is nowhere to be seen. I would place this in the 'too hard' pile until sales and earnings show consistent, tangible improvement.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer